A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany
Clinical trial NCT06104644 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06104644
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-13
- Primary completion
- 2025-08-18
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.